Evidence map›Paper›PMID 24194099›Full record

ReviewMicrobial ecology2014

Evolution of resistance to quorum-sensing inhibitors.

Vipin C Kalia, Thomas K Wood, Prasun Kumar

Abstract readReview
In one paragraph

Review in Microbial ecology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed.

  1. Article
  2. Review
  3. Research Progress on the Quorum Sensing System ofPathogens (Basel, Switzerland) · 2026
    Review
  4. Review
  5. Article
  6. UnderstandingMicroorganisms · 2026
    Review
  7. Review
  8. Review
  9. Review
  10. Antibiotic-ResistantMicroorganisms · 2025
    Review
  11. Article
  12. Review
  13. Evaluation of novel compounds as anti-bacterial or anti-virulence agents.Frontiers in cellular and infection microbiology · 2024
    Review
  14. Article
  15. The IsolatePlants (Basel, Switzerland) · 2023
    Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Anti-bacterial and Anti-biofilm Effects of Equol onIndian journal of microbiology · 2022
    Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Vipin C KaliaMicrobial Biotechnology and Genomics, CSIR-Institute of Genomics and Integrative Biology, Delhi University Campus, Mall Road, Delhi, 110007, India, vckalia@igib.res.in.
Thomas K Wood
Prasun Kumar

Funding

Re-Wiring Cellular Metabolism to Control Biofilm Formation and Virulence BY...R01GM089999 · NIGMS · TEXAS ENGINEERING EXPERIMENT STATION · PI WOOD, THOMAS K · 2009 to 2011
$846k
NIGMS NIH HHS R01 GM089999
6 · The paper itself

Abstract

The major cause of mortality and morbidity in human beings is bacterial infection. Bacteria have developed resistance to most of the antibiotics primarily due to large-scale and "indiscriminate" usage. The need is to develop novel mechanisms to treat bacterial infections. The expression of pathogenicity during bacterial infections is mediated by a cell density-dependent phenomenon known as quorum sensing (QS). A wide array of QS systems (QSS) is operative in expressing the virulent behavior of bacterial pathogens. Each QSS may be mediated largely by a few major signals along with others produced in minuscule quantities. Efforts to target signal molecules and their receptors have proved effective in alleviating the virulent behavior of such pathogenic bacteria. These QS inhibitors (QSIs) have been reported to be effective in influencing the pathogenicity without affecting bacterial growth. However, evidence is accumulating that bacteria may develop resistance to QSIs. The big question is whether QSIs will meet the same fate as antibiotics.

Indexed as

Evolution, MolecularAnti-Bacterial AgentsBacteriaDrug Resistance, BacterialPseudomonas aeruginosaQuorum SensingVirulenceAnti-Bacterial Agents

Identifiers

PMID24194099
PMCPMC4012018

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.